SCHEMBL492490

SCHEMBL492490

COc1ccc(S(=O)(=O)N(C)CCOCC(=O)NC2CCC(C(c3cccc(F)c3)N(C)C)CC2)cc1OC

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.39
ALDH1A1 P00352 6/20 0.38
KMT2A Q03164 4/20 0.38
MEN1 O00255 2/20 0.38
OPRL1 P41146 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
HTT P42858 1/20 0.36
HSD17B10 Q99714 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
GAA P10253 1/20 0.36
PKM P14618 1/20 0.36
POLB P06746 2/20 0.36
HCRTR1 O43613 1/20 0.36
HCRTR2 O43614 1/20 0.36
TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL493119 0.92 KMT2A (0.42) MAPTALDH1A1KMT2AMEN1L3MBTL1
SCHEMBL493185 0.92 MAPT (0.41) MAPTALDH1A1KMT2AMEN1L3MBTL1
SCHEMBL492686 0.91 ALDH1A1 (0.41) ALDH1A1KMT2AOPRL1L3MBTL1SMN1; SMN2
SCHEMBL493055 0.89 OPRL1 (0.39) ALDH1A1KMT2AMEN1OPRL1SMN1; SMN2
SCHEMBL493349 0.88 ALDH1A1 (0.40) MAPTALDH1A1KMT2AMEN1L3MBTL1
SCHEMBL492917 0.87 LMNA (0.47) OPRL1SMN1; SMN2HTTCYP3A4GAA
SCHEMBL493118 0.86 BDKRB1 (0.39) MAPTALDH1A1OPRL1SMN1; SMN2GAA
SCHEMBL492973 0.86 L3MBTL1 (0.42) MAPTOPRL1L3MBTL1SMN1; SMN2HTT
SCHEMBL493262 0.85 BDKRB1 (0.49)
SCHEMBL492545 0.85 BDKRB1 (0.39) KMT2AMEN1OPRL1GAAPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8106055-B2 Substituted amide compounds GRUENENTHAL GMBH (DE) 2012-01-31 US claimed
EP-2139851-A2 SUBSTITUTED AMIDE DERIVATIVES Grünenthal GmbH (DE) 2010-01-06 EP claimed
US-20080306084-A1 Substituted Amide Compounds GRUENENTHAL GMBH (DE) 2008-12-11 US claimed
WO-2008131946-A2 SUBSTITUTED AMIDE DERIVATIVES Grünenthal GmbH (DE) 2008-11-06 WO claimed
US-8106055-B2 Substituted amide compounds GRUENENTHAL GMBH (DE) 2012-01-31 US disclosed
EP-2139851-A2 SUBSTITUTED AMIDE DERIVATIVES Grünenthal GmbH (DE) 2010-01-06 EP disclosed
US-20080306084-A1 Substituted Amide Compounds GRUENENTHAL GMBH (DE) 2008-12-11 US disclosed
WO-2008131946-A2 SUBSTITUTED AMIDE DERIVATIVES Grünenthal GmbH (DE) 2008-11-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306084-A1 Substituted Amide Compounds OPRK1, NAA50, ACMSD MAPT 1653/4885ALDH1A1 1349/4885KMT2A 1749/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.